Morning Market Losers
Biodel (NASDAQ: BIOD) dropped 16.10% to $4.22 after the company's BIOD-123 achieved primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog.
GW Pharmaceuticals plc (NASDAQ: GWPH) plummeted 13.60% to $14.17. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%.
Orbital Corporation Limited (NYSE: OBT) dropped 8.64% to $2.75 after the company announced its plans to cancel United States based ADR program.
BioFuel Energy (NASDAQ: BIOF) dropped 7.59% to $3.91. BioFuel Energy's trailing-twelve-month ROE is -53.62%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.